244 related articles for article (PubMed ID: 12373015)
1. Influence of growth hormone on accretion of bone mass.
Monson JP; Drake WM; Carroll PV; Weaver JU; Rodriguez-Arnao J; Savage MO
Horm Res; 2002; 58 Suppl 1():52-6. PubMed ID: 12373015
[TBL] [Abstract][Full Text] [Related]
2. Skeletal requirements for optimal growth hormone replacement in the transitional years.
Mukherjee A; Attanasio AF; Shalet SM
Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S130-5. PubMed ID: 12914741
[TBL] [Abstract][Full Text] [Related]
3. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth.
Drake WM; Carroll PV; Maher KT; Metcalfe KA; Camacho-Hübner C; Shaw NJ; Dunger DB; Cheetham TD; Savage MO; Monson JP
J Clin Endocrinol Metab; 2003 Apr; 88(4):1658-63. PubMed ID: 12679453
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone and bone health.
Bex M; Bouillon R
Horm Res; 2003; 60 Suppl 3():80-6. PubMed ID: 14671403
[TBL] [Abstract][Full Text] [Related]
5. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
Drake WM; Rodríguez-Arnao J; Weaver JU; James IT; Coyte D; Spector TD; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
[TBL] [Abstract][Full Text] [Related]
6. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
[TBL] [Abstract][Full Text] [Related]
7. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
Kuzma M; Payer J
Cas Lek Cesk; 2010; 149(5):211-6. PubMed ID: 20629339
[TBL] [Abstract][Full Text] [Related]
8. TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY.
Kužma M; Binkley N; Bednárová A; Killinger Z; Vaňuga P; Payer J
Endocr Pract; 2016 Aug; 22(8):951-8. PubMed ID: 27042750
[TBL] [Abstract][Full Text] [Related]
9. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
Kužma M; Kužmová Z; Zelinková Z; Killinger Z; Vaňuga P; Lazurová I; Tomková S; Payer J
Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
[TBL] [Abstract][Full Text] [Related]
10. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
Appelman-Dijkstra NM; Claessen KM; Hamdy NA; Pereira AM; Biermasz NR
Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD.
Baroncelli GI; Bertelloni S; Sodini F; Saggese G
Clin Endocrinol (Oxf); 2004 Feb; 60(2):175-84. PubMed ID: 14725678
[TBL] [Abstract][Full Text] [Related]
12. Bone markers and bone mineral density during growth hormone treatment in children with growth hormone deficiency.
Cowell CT; Woodhead HJ; Brody J
Horm Res; 2000; 54 Suppl 1():44-51. PubMed ID: 11146379
[TBL] [Abstract][Full Text] [Related]
13. Adolescents with childhood-onset GHD: how do we get them to peak bone mass?
Shalet S
Horm Res; 2006; 65 Suppl 2():17-22. PubMed ID: 16707905
[TBL] [Abstract][Full Text] [Related]
14. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
15. Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone mass.
Saggese G; Baroncelli GI; Vanacore T; Fiore L; Ruggieri S; Federico G
J Endocrinol Invest; 2004 Jun; 27(6):596-602. PubMed ID: 15717661
[TBL] [Abstract][Full Text] [Related]
16. Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency.
Elbornsson M; Götherström G; Franco C; Bengtsson BÅ; Johannsson G; Svensson J
Eur J Endocrinol; 2012 Feb; 166(2):181-9. PubMed ID: 22106341
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone mineral density after discontinuation and early reinstitution of growth hormone (GH) in patients with childhood-onset GH deficiency.
Benbassat CA; Wasserman M; Laron Z
Growth Horm IGF Res; 1999 Oct; 9(5):290-5. PubMed ID: 10543936
[TBL] [Abstract][Full Text] [Related]
18. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
19. Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency.
Conway GS; Szarras-Czapnik M; Racz K; Keller A; Chanson P; Tauber M; Zacharin M;
Eur J Endocrinol; 2009 Jun; 160(6):899-907. PubMed ID: 19324976
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone replacement therapy (GHRT) in children and adolescents: skeletal impact.
Mukherjee A; Shalet SM
Med Pediatr Oncol; 2003 Sep; 41(3):235-42. PubMed ID: 12868125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
